Gates Biomanufacturing Facility News & Press Releases

Cell Therapy News


Gates Biomanufacturing Facility Deploys CAR T-Cell Process Improvement

Since receiving FDA approval in 2017, chimeric antigen [...]

Behind the Scenes of a CAR T-Cell Trial

Enrollment has begun for a new phase 1 [...]

New CAR T-Cell Trial Enrolling Patients at CU Anschutz

Enrollment has begun for a new phase 1 [...]

Federal Visit Brings Senator, FDA Commissioner to Campus

The senator and commissioner’s visit included a tour [...]

Podcast: CU Anschutz Powers Up for Regenerative Medicine Frontier

Gates Institute Executive Director Terry Fry, MD, talks [...]

CU Anschutz Takes the Reins in CAR T Cancer Therapy Research

Through university and philanthropic support, coupled with the [...]

Cracking the Code for Once ‘Incurable’ Diseases

Husband-and-wife research team Ganna Bilousova, PhD, and Igor [...]